Immunosuppressants, immunomodulators and COVID-19 vaccines: anticipating patient concerns

J Dermatolog Treat. 2022 May;33(3):1794-1797. doi: 10.1080/09546634.2021.1880543. Epub 2021 Feb 9.

Authors

Jonathan Rick¹, Alyssa M Thompson², Jennifer L Hsiao³, Wilson Liao⁴, Vivian Y Shi¹

Affiliations

¹ Department of Dermatology, University of Arkansas for Medical Sciences, Little Rock, AR, USA.
² College of Medicine, University of Arizona, Tucson, AZ, USA.
³ Department of Medicine, Division of Dermatology, University of California Los Angeles, Los Angeles, CA, USA.
⁴ Department of Dermatology, University of California San Francisco, San Francisco, CA, USA.

PMID: 33494626
DOI: 10.1080/09546634.2021.1880543

No abstract available

Publication types

Letter

MeSH terms

Adjuvants, Immunologic
COVID-19 Vaccines* / adverse effects
COVID-19* / prevention & control
Humans
Immunologic Factors / therapeutic use
Immunosuppressive Agents / adverse effects
SARS-CoV-2
Vaccination

Substances

Adjuvants, Immunologic
COVID-19 Vaccines
Immunologic Factors
Immunosuppressive Agents